• Join
  • Login

Reproductive and genital health in transmasculine people

  • 09/10/2026
  • 1:30 pm
  • Brigante Suite

Addressing Testosterone-Associated Genital Symptoms, Testosterone associated vaginitis, Bleeding and Pregnancy Beyond the Binary

Transmasculine and non-binary people may experience significant reproductive and genital health needs that remain poorly recognised within UK healthcare.

Testosterone-associated vulvovaginitis (TAV) is an under-recognised cause of genitourinary symptoms, with a reported five-year prevalence of approximately 64–78% among transmasculine people receiving testosterone. Vaginal bleeding is also common and may be distressing, yet there is currently limited trans-specific evidence and no universally accepted, evidence-based approach to investigation and management.

This body of work brings together clinical best-practice development and qualitative research to examine the intersecting clinical, reproductive and structural challenges experienced by transmasculine and non-binary people.

A BASHH Gender and Sexual Minorities Special Interest Group working group, reviewed the available evidence and developed a first-in-world best-practice statement for TAV. In the absence of robust trans-specific studies, recommendations draw on relevant guidance concerning menopause-associated and desquamative vaginitis. TAV should be considered in transmasculine patients using testosterone who present with genitourinary symptoms; we discuss assessment, examination and management.

Alongside this, a proposed clinical pathway for testosterone-associated bleeding highlights the importance of considering pregnancy, genital tract infection, cervical pathology, endometrial disease and other causes. Appropriate investigation should be guided by symptoms, anatomy and individual risk. Bleeding may also prompt review and optimisation of gender-affirming treatment. Endometrial cancer, although uncommon, must not be overlooked.

Qualitative research involving trans and non-binary migrants in the UK further demonstrates how migration status, gender identity and race intersect within maternity care. Using reproductive justice and intersectional feminist frameworks, the research explores experiences of antenatal and postnatal services, encounters with healthcare professionals and strategies used to navigate systems shaped by immigration governance and cisnormative assumptions.

Together, these findings highlight the urgent need for national, evidence-informed and inclusive guidance addressing TAV, bleeding, fertility, pregnancy, screening and maternity care. Such guidance should combine clinical safety with culturally competent, trauma-informed and non-discriminatory practice. Robust trans-specific research and studies of marginalised populations, is urgently required to strengthen the evidence base and improve long-term reproductive and genital health outcomes.

Speaker

Attendees

See all Events
AgencyForGood

Copyright 2026. All Rights Reserved